Emergence of YMDD motif mutant of hepatitis B virus during short-term lamivudine therapy in South Korea
โ Scribed by Yong Han Paik; Hyo Young Chung; Wang-Shick Ryu; Kwan Sik Lee; Ji Sook Lee; Jung Hee Kim; Chun Kyun Lee; Chae Yoon Chon; Young Myoung Moon; Kwang-Hyub Han
- Book ID
- 119526592
- Publisher
- Elsevier Science
- Year
- 2001
- Tongue
- English
- Weight
- 272 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Lamivudine is an effective antiviral agent for the treatment of chronic type B hepatitis. Recent studies have shown the appearance of lamivudine resistant viruses with mutations at the tyrosine-methionine-aspartate-aspartate (YMDD) motif of the viral polymerase in hepatitis B virus (HBV) infected pa
Lamivudine is a potent inhibitor of hepatitis B virus (HBV) replication, but its long-term use may be associated with HBV tyrosine-methionine-aspartate-aspartate (YMDD) motif mutation. To examine the clinical features and course after emergence of YMDD mutants, 55 patients who received lamivudine th
Treatment of hepatitis B virus (HBV) with lamivudine is effective in suppressing virus replication and results in reduced inflammatory activity. However, the emergence of lamivudine-resistant mutant virus, with amino acid substitution in the YMDD motif of DNA polymerase, has been reported. We report